Literature DB >> 34120817

A patient-centered gout information value chain: a scoping review.

Maranda J Russell1, Sujin Kim2, Aleksander Lenert3.   

Abstract

OBJECTIVE: To examine and identify the scope of research addressing health information requirements for gout patients using value chain analysis.
METHODS: Five electronic databases (PubMed, CINAHL, ERIC, PsycINFO, Embase, and Scopus) and grey literature (WorldCat) were searched in accordance with a published protocol. Only English language articles were included, with no limitations for date of publication. The findings of the 33 studies included for final analysis were subsequently divided into 6 groups according to the stages of the care delivery value chain their research most closely pertained to: screening/preventing (n = 2), diagnosing (n = 1), preparing (n = 7), intervening (n = 11), recovering/rehabilitating (n = 5), and monitoring/managing (n = 13).
RESULTS: The 33 studies focused on one or more of the following information phenotypes: 1) pathophysiology; 2) medical treatment; and 3) nonpharmaceutical interventions. Long term treatment adherence was a popular topic amongst studies that focused on gout patient education.
CONCLUSION: Based on the identified studies, gout patients are being told what to do, but are not being adequately educated regarding why recommended interventions are important or how to accomplish them. PRACTICE IMPLICATIONS: This review provides a foundation to develop and evaluate personalized education materials using value chain analysis.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34120817      PMCID: PMC8651807          DOI: 10.1016/j.pec.2021.06.007

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  40 in total

1.  Notes from the field: the economic value chain in disease management organizations.

Authors:  Donald Fetterolf
Journal:  Dis Manag       Date:  2006-12

2.  Patients and providers view gout differently: a qualitative study.

Authors:  Leslie R Harrold; Kathleen M Mazor; Sarah Velten; Ira S Ockene; Robert A Yood
Journal:  Chronic Illn       Date:  2010-07-30

3.  2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.

Authors:  Dinesh Khanna; John D Fitzgerald; Puja P Khanna; Sangmee Bae; Manjit K Singh; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

4.  A qualitative and quantitative analysis of the characteristics of gout patient education resources.

Authors:  Philip C Robinson; H Ralph Schumacher
Journal:  Clin Rheumatol       Date:  2013-01-16       Impact factor: 2.980

5.  Rationale and design of the randomized evaluation of an Ambulatory Care Pharmacist-Led Intervention to Optimize Urate Lowering Pathways (RAmP-UP) Study.

Authors:  Brian W Coburn; T Craig Cheetham; Nazia Rashid; John M Chang; Gerald D Levy; Artak Kerimian; Kimberly J Low; David T Redden; S Louis Bridges; Kenneth G Saag; Jeffrey R Curtis; Ted R Mikuls
Journal:  Contemp Clin Trials       Date:  2016-07-20       Impact factor: 2.226

6.  Alcohol intake and risk of incident gout in men: a prospective study.

Authors:  Hyon K Choi; Karen Atkinson; Elizabeth W Karlson; Walter Willett; Gary Curhan
Journal:  Lancet       Date:  2004-04-17       Impact factor: 79.321

Review 7.  Gout: why is this curable disease so seldom cured?

Authors:  Michael Doherty; Tim L Jansen; George Nuki; Eliseo Pascual; Fernando Perez-Ruiz; Leonardo Punzi; Alexander K So; Thomas Bardin
Journal:  Ann Rheum Dis       Date:  2012-08-03       Impact factor: 19.103

8.  Patient and provider barriers to effective management of gout in general practice: a qualitative study.

Authors:  Karen Spencer; Alison Carr; Michael Doherty
Journal:  Ann Rheum Dis       Date:  2012-03-22       Impact factor: 19.103

Review 9.  Treatment approaches and adherence to urate-lowering therapy for patients with gout.

Authors:  Thanda Aung; Gihyun Myung; John D FitzGerald
Journal:  Patient Prefer Adherence       Date:  2017-04-19       Impact factor: 2.711

10.  Adherence with urate-lowering therapies for the treatment of gout.

Authors:  Leslie R Harrold; Susan E Andrade; Becky A Briesacher; Marsha A Raebel; Hassan Fouayzi; Robert A Yood; Ira S Ockene
Journal:  Arthritis Res Ther       Date:  2009-03-27       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.